News

Enter your email address to get Core One Labs News Alerts.

News

Enter your email address to get Core One Labs News Alerts.
Company News
August 18, 2022
Core One Labs’ Akome Achieves Significant Research Milestone with Positive Neurogenesis Stimulation Studies Results
Core One Labs’ Akome Achieves Significant Research Milestone with Positive Neurogenesis Stimulation Studies Results Opening the Door to Expanded Patent Coverage Vancouver,...
Read more
Company News
August 15, 2022
Core One Labs’ Vocan Successfully Converts Psilocin Precursor into Psilocybin
Vancouver, British Columbia, Canada – August 15, 2022 – Further to its press release dated August 12, 2022, Core One Labs Inc. (CSE: COOL), (OTC: Read more
Company News
August 12, 2022
Core One Labs’ Subsidiaries Successfully Produce Psilocin Precursor for Production to Psilocybin
Vancouver, British Columbia, Canada – August 12, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
August 11, 2022
Core One Announces Warrant Repricing
Vancouver, British Columbia, Canada – August 11, 2022 – Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6,...
Read more
Company News
April 06, 2022
Core One Labs’ Upgrades to OTCQB Venture Market
Vancouver, British Columbia, Canada – April 6, 2022 – Core One Labs Inc. (CSE: “COOL”), (OTCQB: “CLABF”), (Frankfurt: LD6, WKN: A3CSSU) (the “Company”...
Read more
Company News
April 02, 2022
Core One Labs’ Akome Receives Positive Results from Bioassay Studies Will Look to Advance its Psychedelic Based Formulations
Vancouver, British Columbia, Canada – April 2, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN: A3CSSU) (the “Company” or “Core One”)...
Read more